Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Monica Peravali"'
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100141- (2021)
Cancer is considered to be an independent risk factor for severe illness and higher mortality in patients with coronavirus disease 2019 (COVID-19). These adverse outcomes have been suspected to be more severe in patients with lung cancer. The objecti
Externí odkaz:
https://doaj.org/article/5ba08eb1e7834233abd64ae7ac802dfd
Autor:
Ishani Joshi, Monica Peravali, Xue Geng, Suman Rao, Kevin Y. Chen, Irina Veytsman, Giuseppe Giaccone, Stephen V. Liu, Chul Kim
Publikováno v:
Clinical Lung Cancer. 23:438-445
While the introduction of immune checkpoint inhibitors (ICI) such as pembrolizumab has significantly improved survival for patients with metastatic non-small cell lung cancer (NSCLC), there remains a need for improved predictive and prognostic biomar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb98d689bcd9ec36ace900a7adddcb6
https://doi.org/10.1016/j.cllc.2022.03.010
https://doi.org/10.1016/j.cllc.2022.03.010
Publikováno v:
Oncologist
Introduction Pembrolizumab, an immune checkpoint inhibitor (ICI), has become an integral part of front-line treatment of metastatic non-small cell lung cancer (NSCLC). However, pivotal trials had significant underrepresentation of Black patients (pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19793b6ed047732c685e480167a6350b
https://doi.org/10.1002/onco.13787
https://doi.org/10.1002/onco.13787
Autor:
Mairead Baker, Mamta Sherchan, Monica Peravali, Irina Veytsman, Eshetu Tefera, Florina Constantinescu, Kenneth D. Burman, Saira Farid, Cristiane Gomes-Lima
Publikováno v:
World Journal of Clinical Oncology
BACKGROUND Immune checkpoint inhibitors (ICPi) cause various immune-related adverse events (irAE) with thyroid dysfunction as a commonly reported abnormality. There is increasing evidence showing positive association with development of irAE and surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e077ede365beaa10196a3f39098ee8
https://doi.org/10.5306/wjco.v12.i2.103
https://doi.org/10.5306/wjco.v12.i2.103
Publikováno v:
JTO Clinical and Research Reports
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100141-(2021)
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100141-(2021)
Cancer is considered to be an independent risk factor for severe illness and higher mortality in patients with coronavirus disease 2019 (COVID-19). These adverse outcomes have been suspected to be more severe in patients with lung cancer. The objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aefc47bfa54dc6568704a109f516177
Publikováno v:
Cancer Research. 81:372-372
Background: The introduction of immune checkpoint inhibitors such as pembrolizumab has significantly improved the outcomes of patients with metastatic non-small cell lung cancer (NSCLC). Pre-treatment biomarkers and clinical parameters such as body m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc448a8566bdc1fe361e5684501bd57a
https://doi.org/10.1158/1538-7445.am2021-372
https://doi.org/10.1158/1538-7445.am2021-372
Publikováno v:
Current oncology reports. 22(12)
Dual inhibition of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) pathways could potentiate improved outcomes in patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC). The purpose of this syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d313e0ca45647348e6c4d83d7b7bed72
https://pubmed.ncbi.nlm.nih.gov/32945977
https://pubmed.ncbi.nlm.nih.gov/32945977
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy
Autor:
Saurabh Dahiya, Perry K. Richardson, Khushali Jhaveri, Aaron P. Rapoport, Ilana Schlam, Monica Peravali, Noa G. Holtzman, Vera Malkovska
Publikováno v:
Blood Adv
Key Points CAR T-cell therapy was safe and effective in a DLBCL patient with coexisting autoimmune neuropathy. CD19 CAR T-cell therapy may control refractory autoantibodies and monoclonal gammopathies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f73f8843c2e3cfc6e8ee4bb969d5bdae
https://pubmed.ncbi.nlm.nih.gov/33284942
https://pubmed.ncbi.nlm.nih.gov/33284942
Autor:
Aarthi Shenoy, Sarah Sewaralthahab, Timothy D. Gilligan, Monica Peravali, Gene Cunningham, Calvin L. Chou, Ilana Schlam, Irina Veytsman
Publikováno v:
Blood. 138:1895-1895
Background Effective feedback is an important tool in medical education for the learning and growth of trainees and for faculty development. It allows learners to remain on course in reaching competence in clinical, research, and interpersonal skills
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35ad4e1fc3a46b479c8448a2fff20f54
https://doi.org/10.1182/blood-2021-153303
https://doi.org/10.1182/blood-2021-153303
Autor:
Aarthi Shenoy, Chidera Nosiri, Christopher S. Hourigan, Christopher Gallagher, Monica Peravali
Publikováno v:
Blood. 136:34-35
Background: Clonal hematopoiesis (CH) increases in inflammatory states, and in retrospective epidemiological studies, has been associated with increased rates of atherosclerotic coronary artery disease, ischemic stroke, neurocognitive disorders, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e424e6b38586b788e5c6a54ba85928
https://doi.org/10.1182/blood-2020-138740
https://doi.org/10.1182/blood-2020-138740